Introduction: Atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS) are one spectrum of rare cutaneous neoplasms that typically arise in sun-exposed skin of older population. AFX/PDS is essentially diagnosis of exclusion requiring Immunohistochemical work-up to exclude other types of tumors. Case Report: We present a case involving an ulcerated solitary lesion on the scalp of an elderly man. Histological examination revealed that the dermal tumor was composed of large pleomorphic, epithelioid, and spindle cells with clear cytoplasm. These cells were negative for cytokeratins, melanocytes and smooth muscle markers, but positive for CD10. These findings are consistent with a diagnosis of clear cell (CC) PDS. Conclusion: PDS is a low-grade malignancy that can recur locally and metastasize, which is distinguished from AFX by its larger size and the presence of aggressive histopathologic features including deeper invasion into the subcutaneous tissue, tumor necrosis, and lymphovascular and/or perineural involvement. Among several histopathologic variants, the CC variant is extremely rare with only two cases of PDS reported in the literature to date.
References
[1]
McCalmont T.H. (2011) AFX: What We Now Know. Journal of Cutaneous Pathology, 38, 853-856. https://doi.org/10.1111/j.1600-0560.2011.01802.x
[2]
Helbig, D., Ziemer, M., Dippel, E., Erdmann, M., et al. (2022) S1-Guideline Atypical Fibroxanthoma (AFX) and Pleomorphic Dermal Sarcoma (PDS). Journal of the German Society of Dermatology: JDDG, 20, 235-243. https://doi.org/10.1111/ddg.14700
[3]
Carletti, M., Nguyen, D.A., Malouf, P., Ingersoll, Z., et al. (2022) Pleomorphic Dermal Sarcoma: A Clinical and Histopathologic Emulator of Atypical Fibroxanthoma, but Different Biologic Behavior. HCA Healthcare Journal of Medicine, 3, 299-304. https://doi.org/10.36518/2689-0216.1334
[4]
Coelho-Lima, J., Bruty, J., Watkins, J., Liu, H., et al. (2022) Clear Cell Variant of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: Molecular Characterization and Review of the Literature. Journal of Cutaneous Pathology, 49, 1031-1034. https://doi.org/10.1111/cup.14307
[5]
Tardío, J.C., Pinedo, F., Aramburu, J.A., Martínez-González, M.á., et al. (2016) Clear Cell Atypical Fibroxanthoma: Clinicopathological Study of 6 Cases and Review of the Literature with Special Emphasis on the Differential Diagnosis. The American Journal of Dermatopathology, 38, 586-592. https://doi.org/10.1097/DAD.0000000000000465
[6]
Kuo, T. (1980) Clear Cell Carcinoma of the Skin. A Variant of the Squamous Cell Carcinoma that Simulates Sebaceous Carcinoma. The American Journal of Surgical Pathology, 4, 573-583. https://doi.org/10.1097/00000478-198012000-00008
[7]
Kazakov, D.V., Ivan, D., Kutzner, H., Spagnolo, D.V., et al. (2009) Cutaneous Hidradenocarcinoma: A Clinicopathological, Immunohistochemical, and Molecular Biologic Study of 14 Cases, Including Her2/neu Gene Expression/Amplification, TP53 Gene Mutation Analysis, and t(11;19) Translocation. The American Journal of Dermatopathology, 31, 236-247. https://doi.org/10.1097/DAD.0b013e3181984f10
[8]
Guillou, L. and Aurias, A. (2010) Soft Tissue Sarcomas with Complex Genomic Profiles. Virchows Archiv: An International Journal of Pathology, 456, 201-217. https://doi.org/10.1007/s00428-009-0853-4
[9]
Mentzel, T., Reisshauer, S., Rütten, A., Hantschke, M., et al. (2005) Cutaneous Clear Cell Myomelanocytic Tumour: A New Member of the Growing Family of Perivascular Epithelioid Cell Tumours (PEComas). Clinicopathological and Immunohistochemical Analysis of Seven Cases. Histopathology, 46, 498-504. https://doi.org/10.1111/j.1365-2559.2005.02105.x